Holistic CRM Care : Optimizing Kidney Protection with SGLT2- inhibitors

Speciality: Nephrology


Speaker:

Professor. Dr. Merlin Thomas | MB ChB, PhD (Medicine) - Specialist in both Nephrology & Endocrinology

Dr. Arpandev Bhattacharya | MBBS, MD - General Medicine, DM – Endocrinology

Description:

A warm welcome to all the medical professionals in this interesting session on Holistic CRM Care : Optimizing Kidney Protection with SLGT2-inhibitor
Holistic care in chronic kidney disease (CKD) management emphasizes kidney protection alongside overall patient well-being, with SGLT2 inhibitors playing a pivotal role. These drugs not only slow CKD progression but also address comorbidities like heart failure and diabetes, reducing hospitalization risks and enhancing quality of life. Their ability to lower albuminuria and improve glycemic control aligns with a patient-centered approach to renal care.
In optimizing kidney protection, SGLT2 inhibitors exemplify the integration of evidence-based medicine into holistic care strategies. By targeting metabolic and hemodynamic pathways, they provide multifaceted benefits, including cardiovascular risk reduction. This comprehensive approach enables healthcare providers to improve outcomes in CKD patients while addressing interconnected health challenges.
Therefore, get an overall knowledge of Holistic CRM Care : Optimizing Kidney Protection with SLGT2-inhibitor. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions
 

See More Webinars @ Hidoc Webinars





Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

2.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

5.

Two medications might work better for breast cancers that are resistant to one.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot